trending Market Intelligence /marketintelligence/en/news-insights/trending/_lGnZaI0v2hUeTml8-_SRw2 content esgSubNav
In This List

Eyegate Pharmaceuticals CFO resigns

Blog

Insight Weekly: Recession risk persists; Banks pull back from crypto; 2022 laggard stocks rally

Blog

Highlighting the Top Regional Aftermarket Research Brokers by Sector Coverage

Blog

Insight Weekly: Inflation eases; bank M&A slows; top companies boost market share

Blog

Insight Weekly: PE firms shift strategies; bank earnings kick off; bankruptcies plummet


Eyegate Pharmaceuticals CFO resigns

Ryan Brenneman is no longer Eyegate Pharmaceuticals Inc.'s CFO and principal financial and accounting officer.

Brenneman resigned from the positions, prompting company President and CEO Stephen From to assume the role of principal financial and accounting officer.